S. Gaur

发表

Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells

Y. Yen, Yun-Ru Chen, H. Forman, 2014, Science Signaling.

NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction

Han Liu, J. Doroshow, S. Gaur, 2017, The Journal of Biological Chemistry.

Phase I trial of fixed-dose rate gemcitabine in combination with bortezomib in advanced solid tumors.

Y. Yen, J. Doroshow, S. Gaur, 2010, Anticancer research.

Alternative splicing as a therapeutic target for human diseases.

Y. Yen, S. Gaur, K. Dery, 2009, Methods in molecular biology.

Mechanistic Control of Carcinoembryonic Antigen-related Cell Adhesion Molecule-1 (CEACAM1) Splice Isoforms by the Heterogeneous Nuclear Ribonuclear Proteins hnRNP L, hnRNP A1, and hnRNP M*

Y. Yen, S. Gaur, K. Dery, 2011, The Journal of Biological Chemistry.

Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.

J. Doroshow, S. Gaur, Xiwei Wu, 2013, Free radical biology & medicine.

Role of Reactive Oxygen Species in the Cytotoxicity of Arsenic Trioxide and Pamidronate for Human Prostate Cancer Cells.

J. Doroshow, S. Gaur, 2020, Reactive oxygen species.

Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer.

Yun Yen, Mark E. Davis, Y. Yen, 2012, Nanomedicine : nanotechnology, biology, and medicine.

Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin.

James H Doroshow, J. Doroshow, S. Gaur, 2007, Biochemical pharmacology.

Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status

Y. Yen, S. Gaur, Yafan Wang, 2014, Molecular Cancer.

Mutants TP53 p.R273H and p.R273C but not p.R273G Enhance Cancer Cell Malignancy

Yate-Ching Yuan, J. Li, Y. Yen, 2014, Human mutation.

Inhibitors of mTOR overcome drug resistance from topoisomerase II inhibitors in solid tumors.

Y. Yen, Lixin Yang, S. Gaur, 2011, Cancer letters.

Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines

S. Gaur, J. Rossi, P. Chomchan, 2011, Leukemia & lymphoma.

The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor

Y. Yen, Lixin Yang, S. Gaur, 2015, Oncotarget.

Altered splicing of CEACAM1 in breast cancer: Identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms

Y. Yen, S. Gaur, J. Shively, 2008, Molecular Cancer.

Effect of Monoamine oxidase A (MAOA) inhibitors on androgen‐sensitive and castration‐resistant prostate cancer cells

Chun-Peng Liao, M. Gross, S. Gaur, 2019, The Prostate.

A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Yun Yen, David Horne, Yate-Ching Yuan, 2013, Cancer research.

Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer.

Yun Yen, Mark E. Davis, Yate-Ching Yuan, 2014, Nanomedicine : nanotechnology, biology, and medicine.